AbbVie is a large-cap US biopharmaceutical company headquartered in North Chicago, Illinois, spun off from Abbott Laboratories in 2013. Its portfolio spans immunology (Humira, Rinvoq, Skyrizi), oncology and hematology (Imbruvica, Venclexta), neuroscience (Botox Therapeutic, Vraylar), and aesthetics (Botox Cosmetic, Juvederm), with revenue driven by a mix of mature franchises and newer growth drivers.
MarketMoodIQ tracks ABBV because large-cap healthcare names act as a defensive sector signal: rotation into or out of pharma often shadows shifts in broader risk appetite that also show up in crypto flows.
LunarCrush has no topic stream for ABBV, so mood, sentiment, and social-volume cards aren't shown — price, market cap, and 24h change come from the equity feed and are accurate.
Research only — not financial advice.